Tag: peanut allergy
Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...
Peanut-allergic patients treated with Palforzia showed desensitization to peanut protein with a predictable safety profile at nine months
Approximately A Third of Pediatricians Fully Follow Guidelines on Peanut Allergy...
"Barriers to implementation are important to address since pediatricians, beginning with the 4-6 month well-child visits, can have a vital role in the reduction of peanut allergy.”
Will the Viaskin “Patch” Therapy for Peanut Allergy be Approved Soon?...
Company is restructuring in anticipation of delays.
AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope...
VeriMAP Peanut Diagnostic has a 93% concordance with food challenge results providing a diagnosis with greater certainty.
Mom, Who Turned 11-Year-Old Tessa’s Death from Anaphylaxis into Life for...
Tessa died after eating a candy bar that triggered anaphylaxis. Her legacy lives on in the lives of others.
New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...
After 2 Years of Daily Treatment, More Than 80% of Patients Were Successfully Desensitized to 2000 mg Peanut Protein or Equivalent of About 14 Peanut Kernels.
New Insights on Allergies May Improve Diagnosis and Treatment
Findings may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.
Amid Coronavirus, Medical Journey Continues for 3-Year-Old Battling Life-Threatening Allergies
Virginia family shares story for Food Allergy Awareness Week.
BlueWillow Completes Preclinical Studies of Intranasal Peanut Allergy Vaccine
Preclinical studies of a peanut vaccine have been completed while the company has begun preclinical studies of a milk allergy vaccine and is ready to begin studies of an egg allergy vaccine.
Among Those Surveyed, One in Seven Peanut Allergic Adults First Developed...
Prevalence study examining peanut allergy characteristics in adults was scheduled to be presented at the 2020 AAAAI Annual Meeting.
